The New York Times Agency May 2010
EN_00913897_9547
(NYT17) HOUSTON -- October 3, 2003 -- Adv. for Sunday, Oct. 5 -- GLAXO-NEW-DRUGS -- Since GlaxoSmithKline's merger, the company has introduced just three new medicines, only one of which it discovered. Nine top scientists who recently left Glaxo said its laboratories' productivity was getting worse, not better. Some scientists say that the very thing that was supposed to bolster the labs' output - the merger - has instead hampered it. Dr. Peter G. Traber, a former VP at GlaxoSmithKline, recently took over as CEO at Baylor College of Medicine in Houston. Traber at the college on July 25, 2003. (Michael Stravato/The New York Times)
CENA MINIMALNA - 100 USD
2003-10-03
EAST NEWS
The New York Times Agency
Michael Stravato/The New York Times/Redux
15374746
0,58MB
14cm x 25cm przy 300dpi
2003, 25, 3, 5, A, ADV, AS, AT, BAYLOR, BETTER, BOLSTER, CEO, COLLEGE, COMPANY, DISCOVERED, DR, FOR, FORMER, GETTING, GLAXO, GLAXOSMITHKLINE, HAMPERED, HAS, HOUSTON, IN, INSTEAD, INTRODUCED, IT, ITS, JULY, JUST, LABORATORIES, LABS, LEFT, MEDIAXPRESS, MEDICINE, MEDICINES, MERGER, MICHAEL, NEW, NINE, NOT, NYT17, OCTOBER, OF, ON, ONE, ONLY, OUTPUT, OVER, PETER, PRODUCTIVITY, RECENTLY, REDUX, SAID, SAY, SCIENTISTS, SINCE, SOME, STRAVATO, SUNDAY, SUPPOSED, THAT, THE, THING, THREE, TIMES, TO, TOOK, TOP, TRABER, VERY, VP, WAS, WHICH, WHO, WIECK, WORSE, YORK,